AI Assurance Lab Concept Leaves Potential Regulatory Gap

In an interview with the Pink Sheet, Troy Tazbaz, director of the US FDA's Digital Health Center of Excellence, says the agency lacks authority to regulate assurance labs, which would be used to help AI developers ensure their models are working correctly before submitting them for approval.

AI in drug development
The FDA is investing in AI lifecycle management, Tazbaz said. • Source: Shutterstock

More from AI

More from Advanced Technologies